PerkinElmer

Newest Assays

To keep up with the speed of your innovation, we strive to provide tools designed to benefit your research. Every day, our R&D scientists are focused on developing fully validated, ready-to-use kits and reagents for the hottest new targets. We’ve added hundreds of new assays to our portfolio and plan on continuing to evolve our product selection as your science evolves.

The products below represent our newest assays. Be sure to check back frequently as we continue to launch new kits.

Most Recently Released Targets
Most Recently Released Targets

Most Recently Released Targets

In the race to the next big breakthrough you need to have the best tools available. We are constantly working to keep pace with the speed of your innovation to provide you with the products you need.

New assays are available in Alpha SureFire® Ultra™, AlphaLISA®, and HTRF® technologies within several different therapeutic areas and research fields.

  • Autoimmunity: Phospho-SQSTM1 p62 (S403)
  • Biologics: IgG1
  • GPCR: Beta-Arrestin Plasmid
  • Immuno-Oncology: Total EGF Receptor L858R, Phospho-VAV1 (Y174), Total VAV1
  • Inflammation: IL-12/IL-23 p40, Total ADAR1, Total cGAS, IL-18
  • Metabolic: Phospho-SQSTM1 p62 (S403)
  • Neuroscience: Phospho-LRRK2 (S955), Total LRRK2, Phospho-SQSTM1 p62 (S403), Phospho-Tau (S214), Phospho-Tau (S404), Phospho-Tau (T181), Phospho-Tau (T205), Phospho-α-Synuclein (S129), Total α-Synuclein, Phospho-ATG16L1 (S278), Total ATG16L1
  • Oncology: Phospho-CDC6 (S54), Phospho-CDC6 (S106), Total CDC6, Total Cyclin E1, Total EGF Receptor L858R, Phospho-HDAC5 (S259), Total HDAC5, Phospho-NPM (T199), Total NPM, Phospho-SQSTM1 p62 (S403), Phospho-VAV1 (Y174), Total VAV1, Phospho-ATG16L1 (S278), Total ATG16L1, Total KRAS, Phospho-CDK1 (T14), Phospho-CDK1 (Y15), Phospho-MET (Y1234/1235), Total MET

Suggested Content

Cisbio Solutions for Autoimmunity Cisbio Solutions for Biologics Cisbio Solutions for GPCRs Cisbio Solutions for Immuno-Oncology Cisbio Solutions for Metabolic Disorders Cisbio Solutions for Neuroscience
Newest Target Video
Newest Target Video

Newest Target Videos

Discover brief animated videos providing information on specific targets and research areas that are addressed by our newly released assays!

Explore Janus Kinases

Explore Janus Kinases

The Power of Cytokines

The Power of Cytokines

Huntingtin Protein

Huntingtin Protein

BRD Proteins as Therapeutic Targets

BRD Proteins as Therapeutic Targets

AAVs as Gene Therapy Vectors

AAVs as Gene Therapy Vectors

Aurora Kinases in the Cell Cycle

Aurora Kinases in the Cell Cycle

Assay Technologies
Assay Technologies

Explore Alpha, HTRF, LANCE Ultra, and DELFIA Assay Technologies

Our Alpha, HTRF®, LANCE® Ultra™ TR-FRET, and DELFIA® TRF technologies offer alternatives to standard ELISA assays, each with a larger dynamic range and higher signal-to-noise ratio. Alpha, HTRF and LANCE Ultra TR-FRET have the added advantage of having no wash or separation steps, saving you valuable time.

Alpha

Alpha

Alpha is a bead-based, no-wash luminescent technology. When Alpha Donor and Acceptor beads are brought together through binding to the target, a cascade of chemical reactions is set in motion, creating an amplified signal. These versatile beads are conjugated with various biomolecules that enable the detection of unique biological events, offering maximum flexibility.

HTRF

HTRF

HTRF (Homogeneous Time Resolved Technology) is a FRET-based, no-wash technology. HTRF technology is rapid, homogeneous, easy to use and to automate, allows extreme miniaturization and easy assay development. HTRF technology can be used in competitive and noncompetitive formats, performed as cellular or biochemical assays, and thus can been applied to a variety of applications.

LANCE

LANCE Ultra

LANCE (Lanthanide Chelate Excite) Ultra TR-FRET is a no wash proximity assay that combines the benefits of time resolution (TR) with fluorescence resonance energy transfer (FRET) principles by using energy donor and energy acceptor fluorophore labels.

DELFIA

DELFIA

DELFIA (dissociation-enhanced lanthanide fluorescence immunoassay) is a time-resolved fluorescence (TRF) intensity technology. DELFIA has a similar assay principle and workflow to that of a traditional ELISA, but with the added benefits of a stable, time-resolved fluorescent signal improving assay dynamic range. DELFIA also offers a multiplexing capability.

Suggested Content

Alpha Technology HTRF (Homogeneous Time Resolved Fluorescence) LANCE Ultra TR-FRET DELFIA TRF Selecting the Right Assay Technology
Products & Services (89)
Filters:

FILTER BY

Expand All Collapse All
Assay Target
  • Alpha-Synuclein (4)
  • BRD2 (4)
  • BRD3 (2)
  • BRD7 (2)
  • c-Met (2)
  • CCL22 (2)
  • CDC6 (6)
  • CDK12 (2)
  • CDK5 (2)
  • CDK6 (2)
  • Cyclin B1 (4)
  • Cyclin E1 (2)
  • EGF Receptor (2)
  • ErbB3 (2)
  • FGFR3 (2)
  • FOXM1 (4)
  • GSK3β (2)
  • H2AX (2)
  • HDAC5 (4)
  • Insulin (2)
  • LRRK2 (4)
  • NPM (4)
  • RBM39 (2)
  • SQSTM1 (2)
  • Tau (8)
  • TDP-43 (6)
  • TOM20 (2)
  • VAV1 (4)
Target Species
  • Human (82)
  • Mouse (34)
Application
  • Protein Analysis & Detection (1)
  • Protein Detection (88)
Therapeutic Area
  • Autoimmunity (2)
  • Immuno-oncology (6)
  • Inflammation (2)
  • Metabolic (6)
  • Neuroscience (30)
  • Oncology (58)
Product Brand Name
  • Alpha CETSA (1)
  • AlphaLISA (6)
  • AlphaLISA SureFire Ultra (78)
  • AlphaLISA SureFire Ultra Multiplex (4)
Experimental Type
  • In vitro (89)

Sort by

1-25 of 89 Products & Services

  • Jump to:
Resource Library (64)
Filters:

FILTER BY

Expand All Collapse All
Events

Sort by

1-1 of 1 Resource Library